144 related articles for article (PubMed ID: 15036857)
1. Cranial nerve palsies in metastatic prostate cancer--results of base of skull radiotherapy.
O'Sullivan JM; Norman AR; McNair H; Dearnaley DP
Radiother Oncol; 2004 Jan; 70(1):87-90. PubMed ID: 15036857
[TBL] [Abstract][Full Text] [Related]
2. Cranial nerve deficits in patients with metastatic prostate carcinoma: clinical features and treatment outcomes.
McDermott RS; Anderson PR; Greenberg RE; Milestone BN; Hudes GR
Cancer; 2004 Oct; 101(7):1639-43. PubMed ID: 15468187
[TBL] [Abstract][Full Text] [Related]
3. The role of palliative radiosurgery when cancer invades the cavernous sinus.
Kano H; Niranjan A; Kondziolka D; Flickinger JC; Lunsford LD
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):709-15. PubMed ID: 18692328
[TBL] [Abstract][Full Text] [Related]
4. Multiple cranial neuropathy as the initial presentation of metastatic prostate adenocarcinoma: case report and review of literature.
Kolias AG; Derham C; Mankad K; Hasegawa H; O'Kane R; Ismail A; Phillips NI
Acta Neurochir (Wien); 2010 Jul; 152(7):1251-5. PubMed ID: 20379748
[TBL] [Abstract][Full Text] [Related]
5. Proton beam radiation therapy for skull base adenoid cystic carcinoma.
Pommier P; Liebsch NJ; Deschler DG; Lin DT; McIntyre JF; Barker FG; Adams JA; Lopes VV; Varvares M; Loeffler JS; Chan AW
Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1242-9. PubMed ID: 17116822
[TBL] [Abstract][Full Text] [Related]
6. [Cranial nerve palsies due to skull base metastases in patients with prostate cancer: a report of two cases].
Kimura M; Satoh T; Fujita T; Matsumoto K; Nishi M; Iwamura M; Kitano M; Ishiyama H; Hayakawa K; Baba S
Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):748-51. PubMed ID: 16898599
[TBL] [Abstract][Full Text] [Related]
7. [Treatment modalities and prognostic factors of chordoma in the skull base].
Qian LT; Liu XF; Li YX
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):635-7. PubMed ID: 16438879
[TBL] [Abstract][Full Text] [Related]
8. Multiple cranial nerve palsies as the presenting features of prostate carcinoma.
Mitchell DM; Wynne CJ; Cowan I
J Med Imaging Radiat Oncol; 2008 Apr; 52(2):194-6. PubMed ID: 18373814
[TBL] [Abstract][Full Text] [Related]
9. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
10. Cranial base chordoma--long term outcome and review of the literature.
Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y
Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191
[TBL] [Abstract][Full Text] [Related]
11. Reversible, isolated, unilateral hypoglossal nerve palsy due to metastatic prostate cancer.
Shah SH
Palliat Med; 2006 Sep; 20(6):639-40. PubMed ID: 17060260
[No Abstract] [Full Text] [Related]
12. Prostate cancer metastasis to clivus causing cranial nerve VI palsy.
Malloy KA
Optometry; 2007 Feb; 78(2):55-62. PubMed ID: 17258159
[TBL] [Abstract][Full Text] [Related]
13. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
Cheung R; Tucker SL; Lee AK; de Crevoisier R; Dong L; Kamat A; Pisters L; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):993-1002. PubMed ID: 15752878
[TBL] [Abstract][Full Text] [Related]
14. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
15. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
Weber DC; Rutz HP; Pedroni ES; Bolsi A; Timmermann B; Verwey J; Lomax AJ; Goitein G
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):401-9. PubMed ID: 16168833
[TBL] [Abstract][Full Text] [Related]
16. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
17. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
18. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
Lee WR; Bae K; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
Cancer; 2007 Apr; 109(8):1506-12. PubMed ID: 17340591
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas.
Schulz-Ertner D; Karger CP; Feuerhake A; Nikoghosyan A; Combs SE; Jäkel O; Edler L; Scholz M; Debus J
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):449-57. PubMed ID: 17363188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
